Canakinumab 100 mg [clinicaltrials_resource:a0fa8ecb2cc83dc7f9086262f50e372c]
intervention [clinicaltrials_vocabulary:intervention]
Canakinumab 100 mg [clinicaltrials_resource:a0fa8ecb2cc83dc7f9086262f50e372c]
Bio2RDF identifier
a0fa8ecb2cc83dc7f9086262f50e372c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a0fa8ecb2cc83dc7f9086262f50e372c
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
100 mg subcutaneous injection once on day 1.
intervention name [clinicaltrials_vocabulary:intervention-name]
Canakinumab 100 mg
identifier
clinicaltrials_resource:a0fa8ecb2cc83dc7f9086262f50e372c
title
Canakinumab 100 mg
@en
type
label
Canakinumab 100 mg [clinicaltrials_resource:a0fa8ecb2cc83dc7f9086262f50e372c]
@en